Bone metastasis pain management with Radium-223
Radium-223 Dichloride (Xofigo®) is indicated for patients who have castration resistant metastatic prostate cancer and who have pain caused by bone metastases.
The treatment consists of 6 intravenous injections, each one of them separated by 4 weeks. The medication will enter the bones via blood circulation and affects the bone lesions, alleviating bone pain. The procedure shall be conducted in an outpatient setting, the patient shall not be hospitalised. You can come to the treatment only with a specialist’s referral.